Pharmaceutical giant Pfizer Inc. announced that it is buying a stake in French gene company Vivet Therapeutics. The deal could be worth as much as $636 million and Pfizer will be paying $51 million up front to take a 15% stake in the Paris-based company. So why would Pfizer want a stake of Vivet? Vivet … Continue reading “Pfizer Is Buying a Big Stake in This Company”
